Mechanisms of Dupilumab in AERD - Effects on Aspirin Hypersensitivity Response, With a Focus on Innate Type 2 Inflammatory Responses
Latest Information Update: 09 Apr 2024
At a glance
- Drugs Dupilumab (Primary)
- Indications Aspirin-induced asthma
- Focus Therapeutic Use
- 03 Apr 2024 Status changed from not yet recruiting to recruiting.
- 07 Feb 2023 Planned End Date changed from 28 Feb 2025 to 28 Feb 2026.
- 07 Feb 2023 Planned primary completion date changed from 31 Dec 2024 to 31 Dec 2025.